Dr. Ghobadi on the Safety of CAR T-Cell Therapy in Hematologic Malignancies
February 13th 2019
Armin Ghobadi, MD, assistant professor of medicine, Division of Medical Oncology, Washington University School of Medicine, Siteman Cancer Center, discusses the safety of chimeric antigen receptor (CAR)-T cell therapy in hematologic malignancies.